We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
5zqu
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN== | ==Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN== | ||
| - | <StructureSection load='5zqu' size='340' side='right' caption='[[5zqu]], [[Resolution|resolution]] 2.60Å' scene=''> | + | <StructureSection load='5zqu' size='340' side='right'caption='[[5zqu]], [[Resolution|resolution]] 2.60Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5zqu]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5ZQU OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5zqu]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5ZQU OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5ZQU FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9HF:1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)benzotriazole-5-carboxylic+acid'>9HF</scene>, <scene name='pdbligand=BR:BROMIDE+ION'>BR</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6003878Å</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9HF:1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)benzotriazole-5-carboxylic+acid'>9HF</scene>, <scene name='pdbligand=BR:BROMIDE+ION'>BR</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5zqu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5zqu OCA], [https://pdbe.org/5zqu PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5zqu RCSB], [https://www.ebi.ac.uk/pdbsum/5zqu PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5zqu ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/RXRA_HUMAN RXRA_HUMAN] Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes.<ref>PMID:10195690</ref> <ref>PMID:11162439</ref> <ref>PMID:11915042</ref> <ref>PMID:20215566</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 18: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5zqu" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5zqu" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Retinoid X receptor 3D structures|Retinoid X receptor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Arulmozhiraja | + | [[Category: Homo sapiens]] |
| - | [[Category: Ikura | + | [[Category: Large Structures]] |
| - | [[Category: Ito | + | [[Category: Arulmozhiraja S]] |
| - | [[Category: Ito | + | [[Category: Ikura T]] |
| - | [[Category: Kakuta | + | [[Category: Ito N]] |
| - | [[Category: Matsuo | + | [[Category: Ito S]] |
| - | [[Category: Miyashita | + | [[Category: Kakuta H]] |
| - | [[Category: Nakano | + | [[Category: Matsuo N]] |
| - | [[Category: Numoto | + | [[Category: Miyashita Y]] |
| - | [[Category: Shimizu | + | [[Category: Nakano S]] |
| - | [[Category: Tokiwa | + | [[Category: Numoto N]] |
| - | + | [[Category: Shimizu K]] | |
| - | + | [[Category: Tokiwa H]] | |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN
| |||||||||||
Categories: Homo sapiens | Large Structures | Arulmozhiraja S | Ikura T | Ito N | Ito S | Kakuta H | Matsuo N | Miyashita Y | Nakano S | Numoto N | Shimizu K | Tokiwa H
